Search global stocks & ETFs...Ctrl K

Learn Mode

BRKR - Bruker Corp

28

$42.75

-$0.13 (-0.303%)

At market close

$42.77

$0.02 (0.036%)

After Hours 5/18/26, 8:02 PM

Score

2.75/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

BRKR

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$6.51B

Industry

Life Sciences Tools & Services

EPS (TTM)

-$0.24

P/E (TTM)

0.00

Div & Yield

$0.20 (0.47%)

FCF Payout Ratio

137.14%

P/S (TTM)

1.88

P/B

2.66

Diluted Shares

152.70M

Ex-Dividend

2026-03-23

Next Earnings

08-03

Forward P/E

18.98

Payout Ratio

0.00%

P/FCF (TTM)

293.13

FCF Yield

0.34%

Earnings Yield

-0.56%

52 Week Range

Score Card

Explore Scores Tab

2.75

Average

Bruker Corp has grown revenue at 0.36% over the past year, which suggests sales are increasing. Also, it has seen its revenue increase by 0.36% over the past year, which suggests sales are growing modestly.

Valuation Model

Key Score

3.00

Average

Management

2.00

Bad

Growth

5.00

Very Good

Profitability

4.00

Good

Fin. Health

5.00

Very Good

Dividends

2.00

Bad

Analyst

5.00

Very Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

4 new filings were in the last 7 days

Filter Form Types

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-18 16:15:08

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-05-15 16:15:17

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-05-15 16:07:30

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-05-15 12:53:56

Form 10-Q

General form for quarterly financial reports under Section 13 or 15(d)

Filed on 2026-05-07 16:09:34

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-05-06 11:06:14

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-05-06 06:30:17

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-28 16:16:18

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-16 16:15:18

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-04-15 16:08:19

Form ARS

Unknown Form Type

Filed on 2026-04-10 16:24:32

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-04-10 16:20:36

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-25

High:

$73.50

71.9%

Avg:

$48.32

13.0%

Low:

$35.35

-17.3%

(% change is relative to the current stock price: $42.75)

Analyst Recommendations

Go to Analyst Tab

3.91

Good

32%

Strong Buy (7)

32%

Buy (7)

32%

Hold (7)

Sell (1)

Strong Sell (0)

About

Website
https://www.bruker.com/
Address
40 Manning Rd, Billerica MASSACHUSETTS, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1109354

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. The firm's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.

IPO Date

2000-08-04

Industry

Life Sciences Tools & Services

Total Employees

11,085

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences

BRKR - Bruker Corp

28

$42.75

-$0.13 (-0.303%)

$42.77

$0.02 (0.036%)

2.75/5

Stock Unlock

Stock Profile

Score Card

Average

Insider Transactions

Market News

Form 4

Filed on 2026-05-18 16:15:08

Form 8-K

Filed on 2026-05-15 16:15:17

Form 144

Filed on 2026-05-15 16:07:30

Form SCHEDULE 13G/A

Filed on 2026-05-15 12:53:56

Form 10-Q

Filed on 2026-05-07 16:09:34

Form SCHEDULE 13G/A

Filed on 2026-05-06 11:06:14

Form 8-K

Filed on 2026-05-06 06:30:17

Form 8-K

Filed on 2026-04-28 16:16:18

Form 4

Filed on 2026-04-16 16:15:18

Form 144

Filed on 2026-04-15 16:08:19

Form ARS

Filed on 2026-04-10 16:24:32

Form DEFA14A

Filed on 2026-04-10 16:20:36

Financials

Price Targets

71.9%

13.0%

-17.3%

Analyst Recommendations

About

Similar Stocks